154 related articles for article (PubMed ID: 38126030)
1. Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p.
Blümke J; Bauer M; Vaxevanis C; Wilfer A; Mandelboim O; Wickenhauser C; Seliger B; Jasinski-Bergner S
Oncoimmunology; 2023; 12(1):2284483. PubMed ID: 38126030
[TBL] [Abstract][Full Text] [Related]
2. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
3. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
Cai L; Li J; Zhang X; Lu Y; Wang J; Lyu X; Chen Y; Liu J; Cai H; Wang Y; Li X
Oncotarget; 2015 Apr; 6(10):7838-50. PubMed ID: 25691053
[TBL] [Abstract][Full Text] [Related]
4. Circulating Epstein-Barr virus microRNAs BART7-3p and BART13-3p as novel biomarkers in nasopharyngeal carcinoma.
Lu T; Guo Q; Lin K; Chen H; Chen Y; Xu Y; Lin C; Su Y; Chen Y; Chen M; Zheng Y; Ye Y; Lin S; Zong J; Pan J
Cancer Sci; 2020 May; 111(5):1711-1723. PubMed ID: 32155300
[TBL] [Abstract][Full Text] [Related]
5. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
7. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma.
Gao W; Li ZH; Chen S; Chan JY; Yin M; Zhang MJ; Wong TS
Oncotarget; 2017 Mar; 8(12):20297-20308. PubMed ID: 28423621
[TBL] [Abstract][Full Text] [Related]
9. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma.
Chan JY; Gao W; Ho WK; Wei WI; Wong TS
Anticancer Res; 2012 Aug; 32(8):3201-10. PubMed ID: 22843893
[TBL] [Abstract][Full Text] [Related]
11. Circulation EBV Mir-Bart-7 Relating to Clinical Manifestation in Nasopharyngeal Carcinoma.
Wardana T; Gunawan L; Herawati C; Oktriani R; Anwar S; Astuti I; Aryandono T; Mubarika S
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2777-2782. PubMed ID: 32986380
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C
FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460
[TBL] [Abstract][Full Text] [Related]
13. EBV-miR-BART7-3p Imposes Stemness in Nasopharyngeal Carcinoma Cells by Suppressing SMAD7.
Cai L; Long Y; Chong T; Cai W; Tsang CM; Zhou X; Lin Y; Ding T; Zhou W; Zhao H; Chen Y; Wang J; Lyu X; Cho WC; Li X
Front Genet; 2019; 10():939. PubMed ID: 31681406
[TBL] [Abstract][Full Text] [Related]
14. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
15. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
16. Novel approach to identify putative Epstein-Barr-virus microRNAs regulating host cell genes with relevance in tumor biology and immunology.
Jasinski-Bergner S; Blümke J; Bauer M; Skiebe SL; Mandelboim O; Wickenhauser C; Seliger B
Oncoimmunology; 2022; 11(1):2070338. PubMed ID: 35529676
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.
Lu Y; Qin Z; Wang J; Zheng X; Lu J; Zhang X; Wei L; Peng Q; Zheng Y; Ou C; Ye Q; Xiong W; Li G; Fu Y; Yan Q; Ma J
J Innate Immun; 2017; 9(6):574-586. PubMed ID: 28877527
[TBL] [Abstract][Full Text] [Related]
18. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
Fachko DN; Chen Y; Skalsky RL
J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
